Transition Preparation Intervention for Young Adults With Type 1 Diabetes
- Conditions
- Type 1 Diabetes
- Interventions
- Behavioral: Transition preparation intervention
- Registration Number
- NCT03998475
- Lead Sponsor
- Virginia Commonwealth University
- Brief Summary
The purpose of this research study is to find out more about how to support young adults (ages 18-22) with type 1 diabetes as they prepare to transition from pediatric and adult endocrinology medical care.
- Detailed Description
The overarching goal of the proposed trial is to improve diabetes self-management and glycemic control in young adults and prepare them for the transition to adult endocrinology. The current application will investigate the impact of a multisystem transition preparation intervention for young adults (ages 18-22) with T1D. Twenty-five young adults and a parent will be enrolled in a 6-month transition preparation program which will use a hybrid in-person and technology delivery structure. Providers will receive training highlighting their role preparing young adults for transition and provides practical tips to use in their communication with young adults. If effective, this multisystem intervention, designed to enhance T1D self-management and increase young adults' readiness for transition to adult healthcare during this critical developmental period, has the potential to inform clinical practice guidelines.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 62
Both members of the youth/parent dyad must meet all eligibility criteria
Young adults
- English-speaking
- patients in Pediatric Endocrinology at Children's Hospital of Richmond (CHoR) at Virginia Commonwealth University (VCU)
- between ages 18-22 yrs with a
- diagnosis of T1D for >1 year
Parents
- greater than 18 years of age
- provide care to the young adult with T1D
- are willing to participate in the intervention
Medical providers
• provide care to patients with T1D ages 18-22 yrs in Pediatric Endocrinology at CHoR
Young adults
- significant psychiatric, cognitive, medical or developmental conditions that would impair their ability to complete assessments and/or engage in diabetes self-care behaviors (e.g., malignancies, psychosis, intellectual disability), as documented in the medical record or revealed during eligibility screening, or
- medically-induced diabetes or diagnosis of diabetes other than type 1 diabetes
Parents
- non-English speaking
- psychiatric, cognitive, or developmental conditions that would impair their ability to complete assessments and/or engage in the intervention as determined at study screening
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Transition preparation program Transition preparation intervention Transition preparation intervention for young adults with type 1 diabetes (T1D)
- Primary Outcome Measures
Name Time Method Number of session views 6 months Number of opened electronic materials (e.g., opened messages in the patient health portal))
Number of sessions attended 6 months Number of study visits (attendance)
Program acceptability - young adult 9 months Young adult report on satisfaction with the program via an exit survey
Program acceptability - parent 9 months Parent report on satisfaction with the program via an exit survey
Program acceptability - provider 9 months Provider report on satisfaction with the program via an exit survey
- Secondary Outcome Measures
Name Time Method Diabetes-related hospitalizations 9 months Participant report and medical record review of count of reported diabetes-related hospitalizations and complications
Change in adherence to diabetes care regimen Baseline to 9 months Average of young adult and parent participant reports on the Diabetes Management Questionnaire (DMQ)
Change in transition readiness Baseline to 9 months Average of young adult and parent participant reports on the Transition Readiness Assessment Questionnaire (TRAQ)
Change in Glycemic control Baseline to 9 months Measurement of hemoglobin A1c (A1c; reported as a percentage)
Trial Locations
- Locations (1)
Children's Hospital of Richmond at Virginia Commonwealth University
🇺🇸Richmond, Virginia, United States